Trimetazidine Use and the Risk of Parkinsonism: A Nationwide Population-Based Study

An association between trimetazidine (TMZ), an anti-anginal drug, and parkinsonism has been reported in a number of studies. However, evidence from studies with long-term follow-up and better validity is lacking. We investigated the risk of TMZ-associated parkinsonism, specifically the incidence rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seungyeon, Yu, Yun Mi, Kwon, Jeongyoon, Jeong, Kyeong Hye, Lee, Jeong Sang, Lee, Euni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579582/
https://www.ncbi.nlm.nih.gov/pubmed/33020406
http://dx.doi.org/10.3390/ijerph17197256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579582/
https://www.ncbi.nlm.nih.gov/pubmed/33020406
http://dx.doi.org/10.3390/ijerph17197256

Ejemplares similares